Arkolith/Insider Trading/CTSO/Form 4

Sobel Alan D.

DirectorCytosorbents Corp (CTSO) · full profile →Form 4 · filed Feb 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Option exercise(O)22K$1.13$25K146K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2025Option exercise(O)22K$1.13$25K0

Transaction Codes

O
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-017618) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML